APA (7th ed.) Citation

S, H., X, S., DH, K., & YJ, L. (2025). The efficacy of hyperthermia-based multimodal therapy is dependent on gatekeeper protein, BID. International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, 42(1), 2544017. https://doi.org/10.1080/02656736.2025.2544017

Chicago Style (17th ed.) Citation

S, Helmueller, Song X, Kim DH, and Lee YJ. "The Efficacy of Hyperthermia-based Multimodal Therapy Is Dependent on Gatekeeper Protein, BID." International Journal of Hyperthermia : The Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group 42, no. 1 (2025): 2544017. https://doi.org/10.1080/02656736.2025.2544017.

MLA (9th ed.) Citation

S, Helmueller, et al. "The Efficacy of Hyperthermia-based Multimodal Therapy Is Dependent on Gatekeeper Protein, BID." International Journal of Hyperthermia : The Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group, vol. 42, no. 1, 2025, p. 2544017, https://doi.org/10.1080/02656736.2025.2544017.